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Abstract  
Introduction: Acute coronary syndromes (ACS) are the major causes of mortality in coronary care units. Inflammation plays 
an important role in ACS.  C-reactive protein (CRP) is one of the inflammatory markers, which plays a key role in the 
pathogenesis. This study aimed at assessing C-reactive protein levels in acute coronary syndromes, and determining its 
significance in prognosis. 
Methods: Fifty patients admitted with the diagnosis of ACS were included in the study. Qualitative C - reactive protein assay 
was done at the time of admission. Patients were followed up for the complications till discharge. 
Results: Age group between 41 to 70 years constituted 40 (80%) patients. Out of 50 patients with acute coronary syndromes 
36 patients had elevated CRP. Thirty patients (83.33%) of them met with complications. Of the 14 patients with low CRP only 
two (14.28%) patients met with the complications. 
Conclusions: Qualitative plasma CRP estimation gives valuable prognostic information in acute coronary syndromes. 
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INTRODUCTION 
 
     Cardiovascular disease is the most common cause of 
mortality worldwide. Earlier thought as the disease of the developed 
world, it is recognized that more cardiovascular deaths occur in 
developing world[1]. The prevalence of cardiovascular diseases in 
India has doubled in rural areas in the last decade. In urban areas it 
has increased from 1% in 1960 to 9.7% in 1995[2].  
     Asian Indians either living in their own country or elsewhere 
have much higher incidence of coronary artery diseases as 
compared to all other ethnic groups. Coronary artery diseases 
among Asian Indians has been found to be more aggressive, diffuse 
and associated with serious complications and increasing mortality at 
a younger age[3]. The classically defined risk factors for 
atherosclerotic arterial disease are hyperlipidemia, hypertension, 
diabetes mellitus and cigarette smoking. In ethnic Asian Indians the 
insulin resistance syndrome, metabolic syndrome X, lipoprotein (a), 
atherogenic dyslipidemic phenotype and some newer emerging risk 
factors (homocysteine, tPA, PAI-1, Fibrinogen, factor VII, infections 
and inflammations.) may be more relevant[4]. An underlying genetic 
susceptibility associated with a modest abnormality in lipids and life 
style factors make coronary artery diseases assume a malignant 
course in Asian Indians. 
     Pathologic data have focused particular attention on the 
fibrous cap at the edge of the atheromatous lesion or shoulder region, 
where inflammatory cells accumulate and plaque rupture most 
frequently occurs. Macrophage and T- cells have been shown to 
dominate at the site of plaque compromise[5]. Laboratory and clinical 
data demonstrate the participation of inflammatory processes at 
every stage of athero-thrombosis.  
     In concert with laboratory data, prospective clinical studies 
have evaluated several acute phase proteins, cytokines and inter-
cellular adhesion molecules as potential novel markers for 
cardiovascular risk assessment. CRP has several characteristics that 
render this inflammatory marker particularly attractive for this 
purpose. CRP is well described as a marker of systemic 
inflammation and is documented to raise several hundred folds in 
response to acute injury, infection, or other inflammatory stimuli. Its 
concentrations remain stable over long periods in the absence of 
new stimuli and depend entirely on the rate of hepatic production, 
rather than factors influencing protein clearance. 
 
METHODOLOGY 
Source of Data 
 
     Fifty patients of acute coronary syndromes (ST Elevation 
Acute myocardial Infarction or Unstable angina/Non ST Elevation 
Myocardial Infarction) admitted to ICCU of Sree Siddhartha Medical 
College, Hospital and who gave written informed consent were the 
subjects. Diagnosis of Acute coronary syndromes was made by 
history, physical examination and electrocardiogram. 
     Patients with stable angina, infectious diseases, neoplastic 
diseases, recent major trauma, recent major surgery, patients on 
immunosuppressive drugs, osteoarthritis, rheumatoid arthritis, 
psoriatic arthritis, gout, immunological disorders, patients on Statins, 
Fibrates, Niacin, Aspirin, patients taking estrogen or progesterone 
pills were excluded from the study. 
     Detailed history, clinical examination and laboratory tests 
were the tools used to exclude these conditions. 
     Apart from routine blood investigations electrocardiography 
and echocardiography was done in all patients. All patients were 
followed up and observed for the development of complications. 
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Procedure for Performing C-reactive protein Assay 
 
     The C reactive protein assay was performed by the rapid slide 
agglutination test for the direct detection and semi-quantitation of C-
reactive protein. The presence of agglutination indicates that the 
content of CRP in the sample equal to or greater than 0.6 mg/dL.  
Homogenous suspension of fluid (without agglutination) indicates a 
CRP level lower than 0.6 mg/dL. 
 
RESULTS 
Age distribution  
 
     Maximum incidence of acute coronary syndrome was 
observed in age group between 41 to 50 years, accounting for 16 
(32%) patients. Age group between 41 to 70 years constituted 40 
(80%) patients. Youngest was 30 years old and suffered STEMI. 
Oldest was 90 years female, who had UA/NSTEMI.
 
Table 1. Distribution of acute coronary syndromes among different Age groups and sex 
 
Age Groups      
In years 
STEMI UA/NSTEMI Total 
Males Females Males Females 
30-40 5 0 1 0 6 
41-50 13 0 2 1 16 
51-60 8 1 1 1 11 
61-70 4 1 3 5 13 
71-80 2 0 1 0 3 
81-90 0 0 0 1 1 
Total 32 2 8 8 50 
 
Sex Distribution 
 
     In this study of the 50 patients we observed, 40(80%) patients 
were males and 10(20%) female patients. There were 34 STEMI 
patients; of these 32 were males and 2 females. And of 16 
UA/NSTEMI, 8 each were from male and female group. Mean age of 
incidence in males was 52.2 years and that for females 64.2 years. 
 
Symptoms 
 
     Chest pain was the most common symptom accounting for 
45(90%) patients, followed by sweating in 32(64%), Breathlessness 
in 18(36%), Vomiting in 11(22%) and Giddiness in 5(10%)  patients. 
 
Risk Factors 
 
     In this study the most common risk factor was Smoking, 
account for 35(70%)  patients followed by Diabetes and 
dyslipidemias. It is noted that out of 40 male patients who suffered 
acute coronary syndromes, 35(87.5%) were smokers. Thus smoking 
was strongly associated with ischemic heart diseases. Diabetes 
mellitus (32%) and lipid abnormalities (50%) were the next common 
risk factors observed. Triglycerides were high and HDL was low in 15 
(30%) patients each. LDL was high in 10 (20%) patients. Five (10%) 
patients had raised total cholesterol.   
 
Classification of Acute Coronary Syndromes 
 
     Out of 50 patients with acute coronary syndromes, 34 patients 
had STEMI and 16 patients had UA/NSTEMI. 
 
Types of ST elevation MI 
 
     Out of the 34 patients of STEMI, fifteen (44%) had extensive 
anterior wall MI followed by 10 (29.4%) patients having antero-septal 
involvement. Antero-lateral wall and inferior wall involvement was 
seen in 2 (5.9%) and 7 (20.6%) patients respectively. 
 
Reperfusion Therapies Performed 
 
     In our hospital pharmacological reperfusion was performed to 
eligible patients with Streptokinase 1.5 million units. So we had 34 
patients with STEMI. Only 15 patients were eligible for Streptokinase 
therapy, and one patient was not thrombolysed due to financial 
constraints. Chest pain of more than 12 hrs and formed Q waves (14 
patients) was the most common cause to withhold thrombolysis 
followed by Hypotension (5 patients). 
 
Complications 
 
     Left ventricular failure was the most common complication 
seen in 15(30%) patients, followed by Cardiogenic shock 6(12%), 
Atrioventricular block 5(10%), and one patient had LBBB. Out of 50 
patients, 5(10%) patients had Ventricular Tachycardia/ Ventricular 
Fibrillation and died. Thus 32(64%) patients suffered from 
complications where as 18(36%) patients did not have any 
complications. Of the 5 patients with AV blocks, 3 patients had 2:1 
Second-degree AV block, one patient had Wenke Bach phenomenon, 
and other had complete heart block.   
 
C reactive Protein Levels at admission 
 
     According to semi-quantitative method of assay of C reactive 
proteins estimation, a level, equal to or more than 0.6 mg/dL is 
detected as positive. A level below 0.6 mg/dL is denoted as negative. 
In our study 36(72%) patients had C reactive protein levels 
detectable (i.e., equal to or more than 0.5 mg/dL). The following table 
shows elevated C reactive Protein levels and their relation to 
complications. 
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Table 2. CRP in patients with and without complications 
 
C Reactive Protein Levels Acute coronary syndromes 
with Complication 
Acute coronary syndromes 
without Complication 
Total 
< 0.6 mg/dL 2 12 14 
 ≥  0.6 mg/dL 30 6 36 
Total 32 18 50 
 
     At one degree of freedom p value is highly significant (p<0.01). 
This indicates that, the patients with high serum C Reactive Level at 
admission are prone for going in to complications. And levels were 
low in patients who did not undergo complications.  
 
Other Investigations 
Erythrocyte Sedimentation Rate 
 
     As ESR is also a marker of inflammation it may also be raised 
in acute coronary syndromes. In this study, ESR was raised in 
32(64%) patients, which include 26 males and 6 females (normal 
values: Males= 0-17mm after 1 hr; Females= 1-25mm after 1 hr). 
 
Total Leukocyte Counts 
 
     Leukocytosis is seen in the setting of acute coronary 
syndrome, but we observed raised leukocyte counts only in 15(30%) 
patients. 
 
Random Blood Glucose 
 
     Raised blood glucose levels were found in 16 (32%) patients 
who were known diabetes mellitus patients. Diabetes mellitus is one 
of the risk factor for ischemic heart disease and is considered as 
ischemic heart disease equivalent. 
 
DISCUSSION 
 
     It is known fact that mean age of development of ACS in 
Indian subcontinent is a decade earlier than western population. In 
our study mean age of patients was 58.21 years. In studies by 
Sueiman et al.,[6] and Foussas et al., [7], ACS was seen in seventh 
decade. Sex distribution in our study was comparable to the previous 
studies with males constituting 80% of the patients. 
 
Risk Factors 
 
     In our study smoking was the most common risk factor, found 
in 35 (70%) patients.  
     In Foussas et al., [7]  study, smoking was observed in 57% of 
patients. In Suleiman et al., [6] study, smoking was observed in 40% 
of patients. Yusuf et al., [8] study, 65.19% of patients were smokers. 
 
Lipid Abnormalities 
 
     In our study 25 (50%) patients had dyslipidemias. Most 
common lipid abnormalities were high triglycerides and low HDL 
levels. In Foussas et al.,[7] study 64.6% of patients had lipid 
abnormalities. And in Suleiman  et al., [6]  study 41% of patients 
had dyslipidemias.  
 
Diabetes Mellitus 
 
     In our study 16 (32%) patients had diabetes as the risk factor. 
In Foussas et al., [7]study Diabetes mellitus was seen in 31% of 
patients and Suleiman et al., [6] study diabetes was present in 30% of 
patients.  
 
Hypertension 
 
     In our study 7 (14%) patients had hypertension. But 
hypertension was seen more frequently in Foussas et al., [7] study 
(51%) and Suleiman et al., (6) study (53%). In “INTER HEART” study 
by Yusuf et al., [8], hypertension was seen in only 19.3% of patients, 
if only South Asian population is considered. 
 
Type of Myocardial Infarction 
 
     In our study 34 (68%) patients had ST segment Elevation 
Myocardial infarction. Almost similar number of patients had ST 
segment Elevation Myocardial infarction in Suleiman et al., [6] study.  
 
Reperfusion Therapy 
 
     In this study only 14 (41%) patients with STEMI underwent 
reperfusion therapy in the form of pharmacological thrombolysis with 
streptokinase. It is comparable to 32% of patients thrombolysed in 
Suleiman et al., [6]  study.  
 
Erythrocyte Sedimentation Rate 
 
     In our study 32 (64%) patients had increased ESR. Similar 
rise was described by Hersberg et al., [9].  
 
C Reactive Protein Levels 
 
     We have studied 50 patients with acute coronary syndromes. 
In this study 36 (72%) patients had raised levels (≥ 0.6mg/dl). And 
30 (60%) patients who had raised levels met with complications.  
 
Comparison to Other Studies 
 
     Foussas et al., studied 1,846 patients with acute coronary 
syndromes and showed that, elevated plasma CRP levels confer a 
significantly increased risk of future fatal or non- fatal ischemic 
complications[7]. Suleiman et al., concluded that, plasma CRP levels 
obtained within 12-24 hours of symptom onset is an independent 
marker of 30 day mortality and the development of heart failure in 
patients with acute myocardial infarction[5]. Bhagat et al., compared 
44 unstable angina patients with 40 age and sex matched healthy 
controls. They concluded that, the plasma CRP is an independent 
predictor of adverse cardiac outcomes in severe unstable angina, in 
short term follow-up and hence is useful for risk stratification of these 
patients[10]. Pietila [11]  showed that, high serum CRP concentrations 
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in acute myocardial infarction patients treated with thrombolytic 
drugs predict increased mortality up to 6 months following the 
myocardial infarction. Tomada et al., [12] studied a total of 234 
patients with acute myocardial infarction, and concluded that CRP 
levels within 6 hours after the onset of symptoms reflect the 
vulnerability of culprit coronary lesions and predict adverse coronary 
events after primary angioplasty. Comparing with these studies, in 
our study also increased levels of plasma C Reactive Protein was 
associated with more adverse events.  
 
CONCLUSIONS 
 
     Qualitative plasma CRP is a simple low cost test easily 
available. Estimation of  CRP can be adopted as a routine test in 
coronary units as it gives a valuable prognostic information. 
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